PATLY.AIApplication
18109031 · Benzylideneaminoguanidine derivatives as NR2B-selective NMDA receptor antagonists and their therapeutic applications
Filed 2023-02-13 · Pending The official file ↗ · Art unit 1618 · Examiner Michael G Hartley Typical · CPC A61K 31/155 · InFlectis BioScience · STITES & HARBISON PLLC
Office actions
3
first was Non-final rejection
RCEs
1
no appeal
To first action
23.3 mo
to disposition n/a
Statutes raised
102 103 112
3 actions read